Dayatan, Jenalyn .
HRN: 27-73-81 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/12/2025
CEFUROXIME 1.5GM (VIAL)
10/12/2025
10/13/2025
IV
1.5 Grams
Every 8 Hours
S/P Diagnostic Curettage And Cervical Punch Biopsy
Checking Final Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes